Adiponectin and resistin modulate the progression of Alzheimer´s disease in a metabolic syndrome model.

Author: CisternasPedro, GherardelliCamila, GutierrezJoel, InestrosaNibaldo C, Mendez-OrellanaCarolina, SalazarPaulina, WongG William

Paper Details 
Original Abstract of the Article :
Metabolic syndrome (MetS), a cluster of metabolic conditions that include obesity, hyperlipidemia, and insulin resistance, increases the risk of several aging-related brain diseases, including Alzheimer's disease (AD). However, the underlying mechanism explaining the link between MetS and brain func...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507329/

データ提供:米国国立医学図書館(NLM)

Adiponectin and Resistin: The Shifting Sands of Alzheimer's Disease

Alzheimer's disease (AD) is a complex and challenging condition that affects millions worldwide. It's like a vast desert of cognitive decline, leaving many feeling lost and disoriented. The researchers in this study delve into the intricate relationship between metabolic syndrome (MetS), a cluster of metabolic conditions often associated with obesity, and AD. They investigated the role of two key players in this intricate dance: adiponectin (ApN) and resistin, both produced by fat cells and known to influence brain function.

This study is like a fascinating expedition through the metabolic desert, using mice models to understand the complex interplay of these molecules in AD. Their research reveals that ApN acts like a refreshing oasis, restoring glucose metabolism, improving cognitive function, and reducing the buildup of amyloid plaques, the characteristic hallmark of AD. In contrast, resistin emerges as a harsh desert wind, exacerbating amyloid pathology and impairing glucose metabolism.

Unraveling the Roles of Adiponectin and Resistin in Alzheimer's Disease

The study results suggest that ApN plays a protective role against AD, while resistin may contribute to its development. This finding is significant, as it provides valuable insight into the potential therapeutic targets for AD treatment.

Potential for Targeting Adipokines in Alzheimer's Treatment

The study results highlight the potential for targeting adipokines, like ApN and resistin, to modify the course of AD. While further research is needed to translate these findings into clinical applications, it offers a promising avenue for developing new treatments for this devastating disease.

Dr.Camel's Conclusion

This research provides a valuable roadmap for navigating the complex desert of Alzheimer's disease. By understanding the intricate roles of adiponectin and resistin, we can develop novel approaches to combatting this devastating condition. It's a reminder that even in the most challenging of deserts, hope and potential solutions can be found.

Date :
  1. Date Completed 2023-09-22
  2. Date Revised 2023-09-22
Further Info :

Pubmed ID

37732123

DOI: Digital Object Identifier

PMC10507329

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.